5-Amino-1MQ (5A1MQ)

Metabolic Preclinical

Small molecule NNMT inhibitor that may enhance fat metabolism and improve metabolic health through epigenetic mechanisms.

Key Data

Research Status
Preclinical
Half-Life
Unknown
Administration
Oral
Typical Dosage
50-150 mg oral

Mechanism of Action

Inhibits nicotinamide N-methyltransferase (NNMT), increasing NAD+ levels and improving fat cell metabolism.

Reported Benefits

All information is presented for Research Use Only (RUO). Not medical advice.

← All Peptides Dosing Calculator Community Forum Home